REPROS THERAPEUTICS INC. 4/A
4/A · REPROS THERAPEUTICS INC. · Filed Mar 10, 2008
Insider Transaction Report
Form 4/AAmended
CAIN DANIEL F
Director
Transactions
- Award
Stock Option (right to buy)
2007-05-15+5,000→ 5,000 totalExercise: $12.37Exp: 2017-05-14→ Common Stock (5,000 underlying)
Holdings
- 2,000
Common Stock
Footnotes (1)
- [F1]The option vests and becomes exercisable as to 100% of the shares subject to the option upon the Annual Meeting of the Stockholders of the issuer following the date of grant so long as the Reporting Person remained a director of Repros Therapeutics Inc. up to the date of the Annual Meeting.